Sensorion raises €50.5 million to advance hearing loss therapies
Sensorion, a biotech company focused on developing novel treatments for hearing loss disorders, announced today that it has raised €50.5 million from a group of investors, including existing shareholders Redmile Group, Invus and Sofinnova Partners, and new US healthcare specialists…